On December 14, 2012, the Federal Circuit issued a 2-1 decision affirming the validity of AstraZeneca PLC’s patent covering Crestor®. The ruling prevents generic versions of the billion-dollar cholesterol-reducing drug until the patent expires in 2016. Finnegan represented AstraZeneca in this matter.
Award/Ranking
Linda Thayer Receives Posthumous 2023 Women, Influence & Power in Law Lifetime Achievement Award
October 19, 2023
Press Release
Finnegan Adds Jenevieve Maerker to Its Trademark, Copyright, and Advertising Practice
April 19, 2023
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.